FFG
EBS icon

Fortem Financial Group’s Emergent Biosolutions EBS Stock Holding History

Fortem Financial Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-530
Closed -$47K – 239
2020
Q4 		$47K Buy
+530
New +$48.6K 0.03% 245
2019
Q2 		– Sell
-4,333
Closed -$219K – 149
2019
Q1 		$219K Buy
4,333
+21
+0.5% +$1.24K 0.23% 105
2018
Q4 		$256K Buy
+4,312
New +$278K 0.31% 71

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortem Financial Group's EBS Position: Q1 2021 in Review

Fortem Financial Group sold out of Emergent Biosolutions (EBS) in Q1 2021, closing a stake of 530 shares — an estimated $47K sold.

Fortem Financial Group first reported a position in EBS in Q4 2018 and held it in 3 quarters. The position peaked at $256K in Q4 2018. 340 funds tracked by Wall St. Rank hold EBS as of Q1 2021.

  • Fortem Financial Group reported no remaining Emergent Biosolutions position as of Q1 2021 after selling out during the quarter.
  • Fortem Financial Group sold 530 Emergent Biosolutions shares in Q1 2021, an estimated $47K.
  • Fortem Financial Group first reported a position in Emergent Biosolutions in Q4 2018 and held it in 3 quarters.
  • Fortem Financial Group's Emergent Biosolutions position peaked at $256K in Q4 2018.
  • 340 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2021.

Based on Fortem Financial Group's 13F filing for Q1 2021, filed 20 Apr 2021.